Responsible Allocation
of Funds Raised
Last
edited on January 27, 2005
Founded by parents
of children with type 1 diabetes, JDRF has a single goal - accelerating
research progress to cure diabetes and its complications. All funds
raised in Australia go towards supporting the best and most promising
Australian research.
JDRF is registered
to fundraise for charitable purposes, where required, in all Australian
states and territories. Currently, for every dollar raised for research
in Australia, up to three additional dollars are allocated by the
international body of JDRFI.
Our research
management process is well respected internationally. We continuously
monitor the global diabetes research landscape, identify gaps in
promising areas of research, and make research investments strategically
to ensure that resources are directed to research with a likely
impact on finding a cure.
Through our
unique scientific peer review and lay review assessment process,
JDRF funds the most innovative, cutting-edge relevant research worldwide.
Our funding and leadership are associated with most of the scientific
breakthroughs in type 1 research, including islet cell transplantation
and stem cell research. We pioneered the creation of multidisciplinary
programs that bring together researchers from many institutions
and disciplines such as molecular biology and genetics, immunology,
transplantation, vascular biology, and stem cells - collaboration
which ensures that progress from research is accelerated as quickly
as possible.
In pursuit of
a cure, JDRF has three research goals:
1. Restoring
normal blood glucose levels
2. Preventing and reversing complications
3. Preventing type 1 diabetes
In Australia
we currently fund 29 separate research projects at research institutions
and universities around the country. Funded researchers are reviewed
annually to ensure their research programs are meeting specified
objectives.
Unlike other
charities, JDRF has only one form of beneficiary, namely research.
The incorrect allocation of funds raised for one beneficiary to
another beneficiary is therefore not possible.
The Board of
Directors of JDRF consists primarily of individuals with a direct
connection with diabetes (usually parent of a child with diabetes).
As such, the board members have vested interest in ensuring all
funds raised are correctly allocated to medical research, hence
speeding up the search for a cure for their loved ones.
Finally, the
Board of JDRF has adopted a high level of corporate governance to
ensure the Foundation is compliant, responsibly managed and directed
in its endeavours to raise funds for research. In line with this
commitment to good corporate governance, adequate internal controls
have been established to ensure the day-to-day financial resources
of the Foundation are responsibly managed with board oversight.
For
further information:
Karolyn Andrews,
Media & PR Manager, JDRF
Ph. 02 9966 0400 (x203) or 0403 787 077 | email: kandrews@jdrf.org.au
|